☆ 4.5 Editorial Material

Thoughts on investigational hedgehog pathway inhibitors for the treatment of cancer

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)

Journal

EXPERT OPINION ON INVESTIGATIONAL DRUGS

Volume 26, Issue 2, Pages 133-136

Publisher

TAYLOR & FRANCIS LTD

DOI: 10.1080/13543784.2017.1274392

Keywords

Hedgehog pathway; inhibitors; drug development

Categories

Pharmacology & Pharmacy

Funding

Anniversary Fund of the Oesterreichische Nationalbank (OeNB) [12677, 14842]
Paracelsus Medical University Salzburg [08/07/037, A- 1 21 021 006-KlE]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Cell Biology

Hedgehog Pathway Inhibitors against Tumor Microenvironment

Silpa Gampala, Jer-Yen Yang

Summary: Targeting the HH pathway for aggressive cancers has been ongoing for decades, with some success but challenges in treating resistance and targeting the tumor microenvironment. Understanding key mechanisms at different levels of tumor development and progression is critical to address various clinical issues.

CELLS (2021)

Add to Collection

Review Pharmacology & Pharmacy

The Hedgehog pathway and its inhibitors: Emerging therapeutic approaches for basal cell carcinoma

Rupesh Jain, Sunil Kumar Dubey, Gautam Singhvi

Summary: Basal cell carcinoma (BCC) is the most common non-melanoma skin cancer. While surgery is the main treatment, targeted combination therapies may be necessary in some cases. The Hedgehog signaling pathway is associated with BCC tumorigenesis and targeting it has potential therapeutic benefits. FDA-approved Hedgehog inhibitors show limited effectiveness against resistant tumors, highlighting the need for a better understanding of the pathway's mechanisms.

DRUG DISCOVERY TODAY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastoma

Xiaohua Liu, Yu Zhang, Yalei Li, Juan Wang, Huaqian Ding, Wenjing Huang, Chunyong Ding, Hongchun Liu, Wenfu Tan, Ao Zhang

Summary: Medulloblastoma is a childhood malignant brain tumor with heterogeneous characteristics and lacks effective molecular targeted therapy. Compounds 25 and 35 show high potency in inhibiting hedgehog signaling and interacting with the transcriptional factor GLI, with potential to combat resistant and wild type smoothened receptor.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Review Cell Biology

Hedgehog Signaling, a Critical Pathway Governing the Development and Progression of Hepatocellular Carcinoma

Jia Ding, Hui-Yan Li, Li Zhang, Yuan Zhou, Jian Wu

Summary: This review focuses on the role and potential mechanisms of Hh signaling in liver cancer, highlighting its impact on HCC initiation, progression, drug resistance, and metastasis. It emphasizes that exploring the deep mechanisms of Hh signaling can guide individualized HCC management.

CELLS (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Design and Synthesis of New Withaferin A Inspired Hedgehog Pathway Inhibitors

Elisa Bonandi, Mattia Mori, Paola Infante, Irene Basili, Lucia Di Marcotullio, Andrea Calcaterra, Federica Catti, Bruno Botta, Daniele Passarella

Summary: Researchers have synthesized a new class of Hh signaling pathway inhibitors inspired by the steroid compound Withaferin A. Through in silico studies and functional evaluation, promising candidate compounds were found, highlighting the importance of natural products as a source of inspiration for novel bioactive compound discovery. The stereoselective approach based on Brown chemistry allowed for the obtainment and functional evaluation of enantiopure hit compounds.

CHEMISTRY-A EUROPEAN JOURNAL (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The Role of Smoothened-Dependent and -Independent Hedgehog Signaling Pathway in Tumorigenesis

Jian Yi Chai, Vaisnevee Sugumar, Mohammed Abdullah Alshawsh, Won Fen Wong, Aditya Arya, Pei Pei Chong, Chung Yeng Looi

Summary: The Hedgehog (Hh)-glioma-associated oncogene homolog (GLI) signaling pathway is highly conserved in mammals and plays crucial roles in cancer initiation and progression. GLI transcription factors are regulated by both SMO-dependent and SMO-independent mechanisms, with dysregulation leading to tumorigenesis in various cancers. Understanding the complex interplay between GLI and signaling elements could inspire new therapeutic breakthroughs for Hh-GLI-dependent cancers.

BIOMEDICINES (2021)

Add to Collection

Review Medicine, General & Internal

Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response

Donatella Gambini, Emanuela Passoni, Gianluca Nazzaro, Giada Beltramini, Gianluca Tomasello, Michele Ghidini, Elisabetta Kuhn, Ornella Garrone

Summary: Basal cell carcinoma (BCC) is a common form of skin cancer that primarily affects elderly patients but can also occur in younger individuals, especially those who are immunocompromised or genetically predisposed. Recent studies have shown a link between BCC development, the Hedgehog (Hh) signaling pathway, and the immune system, specifically in response to Hh pathway inhibitors like vismodegib and sonidegib.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance

Ngoc Minh Nguyen, Jungsook Cho

Summary: This review discusses the importance of the Hedgehog (Hh) signaling pathway in cancer, the emergence of Hh pathway inhibitors, and the mechanisms of drug resistance. Additionally, strategies to overcome resistance are addressed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Pharmacology & Pharmacy

Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer

Xiaomin Wang, Jun Xu, Yiming Sun, Siyuwei Cao, Hanlin Zeng, Nan Jin, Matthew Shou, Shuai Tang, Yi Chen, Min Huang

Summary: This study discovers that the hedgehog (Hh) pathway regulates the histone methylation landscape in breast cancer, promoting histone acetylation and enhancing the therapeutic effect of histone deacetylase (HDAC) inhibitors, providing new treatment options for triple-negative breast cancer (TNBC).

ACTA PHARMACEUTICA SINICA B (2023)

Add to Collection

Review Chemistry, Medicinal

Current approaches and strategies to identify Hedgehog signaling pathway inhibitors for cancer therapy

Zifan Feng, Shanshan Zhu, Wenrui Li, Maojun Yao, Hualong Song, Ru-Bing Wang

Summary: The Hedgehog signaling pathway is crucial in cancer therapy, and inhibitors targeting this pathway have attracted significant interest. Current approaches to developing inhibitors include library screening, natural product-oriented approach, among others.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Medicine, Research & Experimental

The PROTAC selectively degrading Bcl-xL represents a novel Hedgehog pathway inhibitor with capacity of combating resistance to Smoothened inhibitors while bone

Shaoqing Zhang, Yue Chen, Zhongli Xu, Jun Yang, Renhong Sun, Juan Wang, Yiming Sun, Biao Jiang, Xiaobao Yang, Wenfu Tan

Summary: Our study demonstrates that selectively targeting Bcl-xL by PROTAC is a promising strategy for combating resistance to Smo inhibitors without causing on-target drug toxicities of bone growth.

THERANOSTICS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Modulation of Hedgehog Signaling for the Treatment of Basal Cell Carcinoma and the Development of Preclinical Models

Meghan W. Dukes, Thomas J. Meade

Summary: This article discusses the research progress and treatment methods for basal cell carcinoma (BCC). The focus of the study includes chemotherapeutics targeting the Hh pathway and genomic modulation for treatment and research models. Despite existing challenges, targeting the Hh pathway will continue to play a crucial role in research for designing more effective therapies.

BIOMEDICINES (2022)

Add to Collection

Review Oncology

Hedgehog/GLI Signaling Pathway: Transduction, Regulation, and Implications for Disease

Ashley N. Sigafoos, Brooke D. Paradise, Martin E. Fernandez-Zapico

Summary: The Hedgehog/GLI pathway is crucial during development and often dysregulated in diseases like cancer. Activation in cancer is typically through a non-canonical, ligand-independent mechanism. This pathway involves a series of components that work together to repress or activate signaling cascades.

CANCERS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Identification of pseudolaric acid B as a novel Hedgehog pathway inhibitor in medulloblastoma

Su-Fen Wei, Dan-Hua He, Shi-Bing Zhang, Yongzhi Lu, Xiaowei Ye, Xiang-Zhen Fan, Hong Wang, Qi Wang, Yong-Qiang Liu

Summary: The study identified a novel Hh pathway inhibitor, PAB, which significantly inhibited the proliferation of MB cells by suppressing the expression of Gli1 and its target genes, as well as blocking ciliogenesis. PAB shows potential to overcome drug-resistance induced by SMO mutations, making it a promising therapeutic option for Hh-dependent MB cases resistant to SMO antagonists.

BIOCHEMICAL PHARMACOLOGY (2021)

Add to Collection

Article Marine & Freshwater Biology

Cadmium impairs zebrafish swim bladder development via ROS mediated inhibition of the Wnt / Hedgehog pathway

Ting Zhang, Canchuan Zhang, Jin Zhang, Jiangtian Lin, Dongdong Song, Peng Zhang, Yang Liu, Lizhao Chen, Li Zhang

Summary: This study reveals the molecular mechanisms of cadmium toxicity on the early development of the swim bladder in zebrafish. Cadmium exposure inhibits Wnt and Hedgehog signaling pathways, disturbs surfactant lipid distribution, and impairs the formation of the swim bladder's tissue layers, leading to developmental defects.

AQUATIC TOXICOLOGY (2022)

Add to Collection

Article Surgery

Outcome of Radical Surgery for Simultaneous Liver and Lung Metastases Synchronous with Primary Colorectal Cancer

Franz Xaver Singhartinger, Martin Varga, Tarkan Jager, Adam Dinnewitzer, Oliver Koch, Burkhard H. A. von Rahden, Jorg Hutter, Klaus Emmanuel

Summary: Colorectal cancer (CRC) often leads to metastatic disease in approximately 30% of patients. This study retrospectively analyzed CRC patients with simultaneous liver and lung metastasis undergoing resection with curative intent, showing that patients seemed to benefit from the surgery with tendency to prolonged OS and acceptable complication rate, although tumor recurrence occurred in all cases. Repeated resection of recurrent metastases led to further prolonged OS in some cases.

INDIAN JOURNAL OF SURGERY (2022)

Add to Collection

Review Surgery

A systematic review on diagnostics and surgical treatment of adult right-sided Bochdalek hernias and presentation of the current management pathway

J. P. Ramspott, T. Jaeger, M. Lechner, P. Schredl, A. Gabersek, F. Mayer, K. Emmanuel, S. Regenbogen

Summary: Bochdalek hernia is a rare congenital diaphragmatic hernia with a higher incidence in middle-aged and older women. Symptoms typically include abdominal pain and dyspnea, necessitating prompt surgical repair and regular follow-up. There is a great need for high-quality studies on the management of this rare entity.

HERNIA (2022)

Add to Collection

Review Pharmacology & Pharmacy

Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned?

Christian Mayr, Tobias Kiesslich, Dominik Paul Modest, Sebastian Stintzing, Matthias Ocker, Daniel Neureiter

Summary: This review provides an update on the resistance mechanisms of BTC to conventional chemotherapy and targeted therapies. It summarizes the known mechanisms of drug resistance in BTC and highlights the need for better monitoring methods for cellular changes. A specific and effective approach for BTC treatment is currently lacking.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)

Add to Collection

Article Surgery

Incidence and risk factors for umbilical incisional hernia after reduced port colorectal surgery (SIL+1 additional port)-is an umbilical midline approach really a problem?

Peter Tschann, Daniel Lechner, Paolo N. C. Girotti, Stephanie Adler, Stephanie Rauch, Jaroslav Presl, Tarkan Jager, Philipp Schredl, Christof Mittermair, Philipp Szeverinski, Patrick Clemens, Helmut G. Weiss, Klaus Emmanuel, Ingmar Koenigsrainer

Summary: This study evaluated the incidence and risk factors for incisional hernia after reduced port colorectal surgery. The results showed that obesity and pre-existing umbilical hernia were significant risk factors for incisional hernia. Reduced port colorectal surgery using an umbilical single port access was demonstrated to be feasible and safe, with a low rate of incisional hernia.

LANGENBECKS ARCHIVES OF SURGERY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Pharmacologic Antagonization of Cannabinoid Receptor 1 Improves Cholestasis in Abcb4-/- Mice

Nora Helmrich, Martin Roderfeld, Anne Baier, Anita Windhorst, Diran Herebian, Ertan Mayatepek, Christian Dierkes, Matthias Ocker, Dieter Glebe, Bruno Christ, Yuri Churin, Karuna Irungbam, Elke Roeb

Summary: This study found that pharmacologic antagonization of CB1 receptor improved chronic cholestasis-induced liver damage, bile duct proliferation, and other symptoms in the Abcb4(-/-) mouse model. The results also suggest that the antagonization of CB1 receptor could have therapeutic benefits in cholestasis-associated metabolic changes, inflammation, and carcinogenesis.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Review Oncology

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation

Dino Bekric, Matthias Ocker, Christian Mayr, Sebastian Stintzing, Markus Ritter, Tobias Kiesslich, Daniel Neureiter

Summary: In recent years, scientific discoveries have brought new breakthroughs in the treatment of hepatocellular carcinoma (HCC). Ferroptosis, as a novel form of cell death, may negatively impact HCC and serve as a potential anti-cancer strategy. Understanding the role of ferroptosis in HCC and its application in clinical practice is of great importance.

CANCERS (2022)

Add to Collection

Editorial Material Surgery

A systematic review on diagnostics and surgical treatment of adult right-sided Bochdalek hernias and presentation of the current management pathway. Author's reply COMMENT

J. P. Ramspott, M. Lechner, T. Jager, K. Emmanuel, S. Regenbogen

HERNIA (2022)

Add to Collection

Article Oncology

Is Robotic Assisted Colorectal Cancer Surgery Equivalent Compared to Laparoscopic Procedures during the Introduction of a Robotic Program? A Propensity-Score Matched Analysis

Peter Tschann, Markus P. Weigl, Daniel Lechner, Christa Mittelberger, Tarkan Jaeger, Ricarda Gruber, Paolo N. C. Girotti, Christof Mittermair, Patrick Clemens, Christian Attenberger, Philipp Szeverinski, Thomas Brock, Juergen Frick, Klaus Emmanuel, Ingmar Koenigsrainer, Jaroslav Presl

Summary: This study aimed to compare the short-term outcomes and oncological findings of robotic-assisted colorectal resections with conventional laparoscopic surgery within the first three years after the introduction of the robotic platform. The results of the study clearly demonstrated that robotic-assisted colorectal cancer surgery was equally effective, feasible, and safe compared to conventional laparoscopy during the introduction phase of a robotic system.

CANCERS (2022)

Add to Collection

Review Cell Biology

Patient Selection Approaches in FGFR Inhibitor Trials-Many Paths to the Same End?

Peter Ellinghaus, Daniel Neureiter, Hendrik Nogai, Sebastian Stintzing, Matthias Ocker

Summary: Inhibitors of fibroblast growth factor receptor (FGFR) signaling have shown promise in various human cancer diseases. Different technologies have been employed in clinical trials to identify predictive biomarkers for FGFR targeting therapies, each with its own advantages and limitations. Tissue and disease context play a crucial role in determining the best biomarker for these therapies.

CELLS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model

Mari I. Suominen, Matias Knuuttila, Christoph A. Schatz, Andreas Schlicker, Jukka Vaaraniemi, Birgitta Sjoholm, Esa Alhoniemi, Bernard Haendler, Dominik Mumberg, Sanna-Maria Kakonen, Arne Scholz

Summary: In this study, the antitumor efficacy of radium-223, enzalutamide, and their combination was evaluated in a model of prostate cancer metastasis to bone. The combination treatment showed synergistic efficacy and enhanced antitumor effect in vitro and in vivo without compromising healthy bone integrity. These results support the ongoing phase 3 trial of radium-223 and enzalutamide combination therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Review Oncology

How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant Therapy

Falk Roeder, Sabine Gerum, Stefan Hecht, Florian Huemer, Tarkan Jaeger, Reinhard Kaufmann, Eckhard Klieser, Oliver Owen Koch, Daniel Neureiter, Klaus Emmanuel, Felix Sedlmayer, Richard Greil, Lukas Weiss

Summary: The treatment of locally advanced rectal cancer has changed significantly, with the introduction of total neoadjuvant therapy, non-operative management for patients with clinical complete responses after neoadjuvant treatment, and upfront immunotherapy for patients with MSI-high/dMMR tumors.

CANCERS (2022)

Add to Collection

Article Oncology

Identification of Risk Factors for Sexual Dysfunction after Multimodal Therapy of Locally Advanced Rectal Cancer and Their Impact on Quality of Life: A Single-Center Trial

Peter Tschann, Markus Weigl, Thomas Brock, Juergen Frick, Oliver Sturm, Jaroslav Presl, Tarkan Jaeger, Michael Weitzendorfer, Philipp Schredl, Patrick Clemens, Helmut Eiter, Philipp Szeverinski, Christian Attenberger, Veronika Tschann, Walter Brunner, Alexander De Vries, Klaus Emmanuel, Ingmar Koenigsrainer

Summary: Sexual dysfunction after rectal cancer surgery is common and often untreated, especially in female patients. This study identified age, female sex, distal tumors, and extensive surgery (APR and ISR) as risk factors for sexual dysfunction. It also found that extensive surgery (APR or ISR) may affect quality of life.

CANCERS (2022)

Add to Collection

Article Nutrition & Dietetics

Sarcopenic Obesity Is a Risk Factor for Worse Oncological Long-Term Outcome in Locally Advanced Rectal Cancer Patients: A Retrospective Single-Center Cohort Study

Peter Tschann, Markus P. Weigl, Patrick Clemens, Philipp Szeverinski, Christian Attenberger, Matthias Kowatsch, Tarkan Jaeger, Klaus Emmanuel, Thomas Brock, Ingmar Koenigsrainer

Summary: This study evaluated body composition indices in locally advanced rectal cancer patients prior to therapy and their impact on short- and long-term outcomes. The results showed that muscle waste, age, and comorbidities were strong risk factors for increased overall morbidity. Sarcopenic obesity was significantly associated with worse disease-free survival and overall survival. This study highlights the importance of nutrition and appropriate physical activity prior to therapy.

NUTRIENTS (2023)

Add to Collection

Article Oncology

The SAlzburg PEritoneal SUrface CAlculator (SAPESUCA): The First Web-Based Application for Peritoneal Surface Area Quantification

Tarkan Jaeger, Philipp Schredl, Daniel Neureiter, Jaroslav Presl, Peter Tschann, Ingmar Koenigsrainer, Andreas Pascher, Klaus Emmanuel, Stephan Regenbogen, Jan Philipp Ramspott

Summary: The combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) has shown promise in treating select patients with peritoneal metastases. However, standardization of these procedures is lacking, and the variability in resection and dosing regimens complicates implementation. This article introduces SAPESUCA, a web-based app that allows for standardized documentation of peritonectomy extent and determination of HIPEC dose based on peritoneal surface area. SAPESUCA is a valuable tool in the standardization of cytoreductive surgery and HIPEC.

CANCERS (2023)

Add to Collection

Article Surgery

Are risk factors for anastomotic leakage influencing long-term oncological outcomes after low anterior resection of locally advanced rectal cancer with neoadjuvant therapy? A single-centre cohort study

Peter Tschann, Markus P. Weigl, Philipp Szeverinski, Daniel Lechner, Thomas Brock, Stephanie Rauch, Jana Rossner, Helmut Eiter, Paolo N. C. Girotti, Tarkan Jaeger, Jaroslav Presl, Klaus Emmanuel, Alexander De Vries, Ingmar Koenigsrainer, Patrick Clemens

Summary: This study identified tumor distance from the anal verge and comorbidities as independent risk factors for the occurrence of anastomotic leakage following rectal cancer surgery. However, these specific risk factors do not influence the oncological outcome and long-term prognosis.

LANGENBECKS ARCHIVES OF SURGERY (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.